Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM/AREC stock hub

AIM/AREC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/ARECis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

24.9M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/AREC

In the news

Latest news · AIM/AREC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/E33

P25 15.9P50 22.9P75 35.8

ROE15.8

P25 -54.2P50 2.1P75 13.7

ROIC-484.7

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/AREC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

GBP

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	44
Employees Change	-6%
Employees Change Percent	-12
Enterprise value	GBX 18.9M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BMWLM973
Last refreshed	2026-05-10
Market cap	GBX 24.9M
Price	GBX 66
Price currency	GBX
Rev Per Employee	38,954.55x
Sector	Healthcare
Sic	2836
Symbol	aim/AREC
Website	https://arecor.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.66%
EV Earnings	28.44x
EV/FCF	-7.67x
EV/Sales	11.02x
FCF yield	-9.88%
P/B ratio	3.86x
P/E ratio	33x
P/S ratio	14.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-236%
EBITDA Margin	-229.17%
Gross margin	73.86%
Gross Profit	GBX 1.3M
Gross Profit Growth	-19.52%
Gross Profit Growth3 Y	32%
Gross Profit Growth5 Y	-15.22%
Net Income	GBX 664,000
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	57.99%
Profit Margin	38.74%
Profit Per Employee	GBX 15,091
Profitable Years	1
ROA	-30.06
Roa5y	-29.54
ROCE	-62.32
ROE	15.79
Roe5y	-46.46
ROIC	-484.7
Roic5y	-929.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	73.75%
Cagr3y	-37.47%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth	-65.56x
Revenue Growth Years	0x
Revenue Growth3 Y	-28.74x
Revenue Growth5 Y	-9.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.2
Assets	GBX 8.1M
Cash	GBX 6.1M
Current Assets	GBX 7.7M
Current Liabilities	GBX 1.6M
Debt	GBX 98,000
Debt Equity	GBX 0.02
Debt FCF	GBX -0.04
Equity	GBX 6.5M
Interest Coverage	-367.7
Liabilities	GBX 1.6M
Long Term Assets	GBX 399,000
Long Term Liabilities	GBX 37,000
Net Cash	GBX 6M
Net Cash By Market Cap	GBX 24.21
Net Cash Growth	99.4%
Net Debt Equity	GBX -0.93
Tangible Book Value	GBX 6.4M
Tangible Book Value Per Share	GBX 0.17
WACC	3.12

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.78
Net Working Capital	GBX 58,000
Quick ratio	4.22
Working Capital	GBX 6.1M
Working Capital Turnover	GBX 0.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-23.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	73.68%
200-day SMA	72.55
3Y total return	-75.56%
50-day SMA	68.03
50-day SMA vs 200-day SMA	50under200
All Time High	472
All Time High Change	-86.02%
All Time High Date	2021-09-23
All Time Low	35.4
All Time Low Change	86.44%
All Time Low Date	2025-04-22
ATR	4.67
Beta	-0.21
Beta1y	0.06
Beta2y	0.45
Ch YTD	-18.01
High	68.87
High52	100
High52 Date	2025-09-25
High52ch	-34%
Low	66
Low52	38
Low52 Date	2025-05-08
Low52ch	78.38%
Ma50ch	-2.98%
Price vs 200-day SMA	-9.03%
RSI	40.56
RSI Monthly	39.07
RSI Weekly	39.99
Sharpe ratio	1.47x
Sortino ratio	2.98
Total Return	-23.12%
Tr YTD	-18.01
Tr1m	2.33%
Tr3m	-14.84%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -4M
Operating margin	-236

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	21,260,046%
Net Borrowing	-88,000
Shares Insiders	15.96%
Shares Institutions	45.71%
Shares Out	37,756,601
Shares Yo Y	23.12%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -2.8M
Average Volume	11,983.45x
Bv Per Share	0.17
CAPEX	GBX -99,000
Ch1m	2.33
Ch1y	73.68
Ch3m	-14.84
Ch3y	-75.56
Ch6m	-12
Change	0%
Change From Open	0
Close	66
Days Gap	0
Depreciation Amortization	117,000
Dollar Volume	1,650,000
Earnings Date	2026-04-13
EBIT	GBX -4M
EBITDA	GBX -3.9M
EPS	GBX 0.01
F Score	3
FCF	GBX -2.5M
FCF EV Yield	-13.04x
FCF Per Share	GBX -0.07
Financing CF	-148,000
Fiscal Year End	December
Founded	2,007
Graham Number	22.535
Graham Upside	-65.86
Income Tax	GBX 62,000
Investing CF	2,457,000
Is Primary Listing	1
Last Earnings Date	2026-04-13
Last Report Date	2025-12-31
Ma150	74.24
Ma150ch	-11.1%
Ma20	65.93
Ma20ch	0.11%
Net CF	-238,000
Next Earnings Date	2026-06-25
Open	66
Position In Range	0
Ppne	298,000
Price Date	2026-05-08
Ptbv Ratio	3.87
Relative Volume	2.13x
Revenue	1,714,000x
SBC By Revenue	18.9x
Share Based Comp	324,000
Tax By Revenue	3.62x
Tax Rate	6.24%
Tr6m	-12%
Volume	25,000
Z Score	-0.11

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/AREC pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/AREC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/AREC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+45.7%

Share of float held by funds and institutions

Insider ownership

+16.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+23.1%

Negative means the company is buying back shares.

Technical

AIM/AREC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.6

Neutral momentum band

Price vs 200-day MA

-9.0%

50/200-day relationship not available

Beta (5Y)

-0.21

Less volatile than the market

Sharpe ratio

1.47

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/AREC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/AREC stock rating?

aim/AREC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/AREC analysis?

The full report lives at /stocks/aim/AREC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/AREC?

The latest report frames aim/AREC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/AREC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.